Inhibrx Biosciences Inc. (INBX)
NASDAQ: INBX
· Real-Time Price · USD
12.90
-0.10 (-0.77%)
At close: Jun 05, 2025, 3:59 PM
12.89
-0.12%
After-hours: Jun 05, 2025, 04:04 PM EDT
-0.77% (1D)
Bid | 10 |
Market Cap | 186.81M |
Revenue (ttm) | 200K |
Net Income (ttm) | 1.72B |
EPS (ttm) | 119.02 |
PE Ratio (ttm) | 0.11 |
Forward PE | -1.41 |
Analyst | n/a |
Ask | 14.24 |
Volume | 40,602 |
Avg. Volume (20D) | 110,079 |
Open | 12.85 |
Previous Close | 13.00 |
Day's Range | 12.80 - 13.16 |
52-Week Range | 10.80 - 17.79 |
Beta | -0.28 |
About INBX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol INBX
Website n/a
3 weeks ago
+10.89%
Inhibrx Biosciences shares are trading higher afte...
Unlock content with
Pro Subscription

7 months ago · seekingalpha.com
Inhibrx Biosciences: Reincorporated And Trying To Find A Niche With Unique PlatformINBX's two main pipeline candidates, INBRX-109 and INBRX-106, are entering critical late-stage trials with data readouts expected in mid- to late-2025. INBRX-109 targets DR5 in solid tumors, showing p...